• Rehabilitation outcomes and dosing emerged as a central paradigm in stroke care, linking functional recovery to structured therapy and elderly management. Key work includes outcome-focused rehab in stroke [18], therapy intensity in stroke patients [15], early controlled elderly stroke rehab [14], and systematic rehabilitation assessment in the Harvard Stroke Registry [2].

• Pharmacologic and physiological interventions dominated acute stroke research, spanning anticoagulation, edema control, and brain-energy metabolism. Evidence from Barbiturate protection [19], anticoagulant strategies [13], The use of anticoagulants in cerebral thrombosis [8], edema pathology [12], and cerebral energy studies [16], [17].

• Epidemiology, risk factors, and incidence trends framed prevention and public health responses. Core threads include cerebrovascular disease epidemiology [9], the declining incidence of stroke [10], TIAs and stroke risk factors [1][5], and Hiroshima vascular epidemiology [11].

• Vascular interventions and disease mechanisms informed both surgical and medical management, emphasizing carotid reconstruction and vascular etiologies. The carotid artery reconstruction case [6], plus anticoagulant-focused trials [13][8], illuminate interventional pathways shaping early stroke care.

• Natural history and prognosis frameworks emerged to guide care decisions, outlining trajectories and informing outcome expectations. Rochester stroke natural history [3], natural history observations in transient ischemia [4], and prognosis in transient attacks [20] illustrate evolving baselines for stroke care planning.